Haelan 951
Commercial- Indications
- Nutritional support
Company intelligence / Profile preview
Haelan 951 is a commercially available, fermented soy beverage marketed as a dietary supplement, with some clinical and preclinical studies suggesting possible benefits in supporting cancer patients, including improvement of appetite, reduced inflammation, and enhanced immune response. Most evidence remains preliminary and focused on supportive/nutritional endpoints rather than regulated drug outcomes.[1][4][5][6][7]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Haelan Products.